We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+15.59%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.21B
AUM Growth
+$172M
Cap. Flow
-$45.2M
Cap. Flow %
-2.05%
Top 10 Hldgs %
35.68%
Holding
326
New
54
Increased
55
Reduced
104
Closed
52

Top Sells

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$38.5M
2
PYPL icon
PayPal
PYPL
+$30.6M
3
TSLA icon
Tesla
TSLA
+$30.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26M
5
UNH icon
UnitedHealth
UNH
+$24M

Sector Composition

Rank Sector Weight
1 Technology 30.45%
2 Healthcare 15.53%
3 Consumer Discretionary 12.94%
4 Industrials 9.32%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIX icon
126
WIX.com
WIX
$2.56B
$4.25M 0.19%
54,340
-13,180
-20% -$1.08M
NEO icon
127
NeoGenomics
NEO
$1.99B
$4.22M 0.19%
262,507
+29,140
+12% +$480K
TENB icon
128
Tenable Holdings
TENB
$3.47B
$4.21M 0.19%
96,710
-870
-0.9% -$35.5K
ALTR
129
DELISTED
Altair Engineering Inc
ALTR
$4.12M 0.19%
54,380
-490
-0.9% -$35K
MAS icon
130
Masco
MAS
$14.6B
$4.12M 0.19%
71,800
SWAV
131
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3.9M 0.18%
+13,680
New +$3.8M
SHLS icon
132
Shoals Technologies Group
SHLS
$1.33B
$3.89M 0.18%
152,140
+147,860
+3,455% +$3.42M
CRSR icon
133
Corsair Gaming
CRSR
$1.1B
$3.89M 0.18%
+219,020
New +$3.99M
SIBN icon
134
SI-BONE Inc
SIBN
$818M
$3.85M 0.17%
+142,762
New +$3.48M
DGII icon
135
Digi International
DGII
$2.47B
$3.83M 0.17%
97,110
-59,680
-38% -$2.05M
APLS
136
DELISTED
Apellis Pharmaceuticals
APLS
$3.72M 0.17%
+40,820
New +$3.52M
XENE icon
137
Xenon Pharmaceuticals
XENE
$6.1B
$3.64M 0.16%
94,490
+16,750
+22% +$666K
PERI icon
138
Perion Network
PERI
$380M
$3.55M 0.16%
+115,860
New +$3.98M
PCVX icon
139
Vaxcyte
PCVX
$7.65B
$3.45M 0.16%
+69,000
New +$3.27M
TXG icon
140
10x Genomics
TXG
$5.88B
$3.42M 0.16%
+61,310
New +$3.32M
BDC icon
141
Belden
BDC
$3.97B
$3.37M 0.15%
35,200
-26,610
-43% -$2.28M
WES icon
142
Western Midstream Partners
WES
$19.4B
$3.36M 0.15%
126,800
-59,420
-32% -$1.56M
CIVI
143
DELISTED
Civitas Resources
CIVI
$3.35M 0.15%
+48,230
New +$3.34M
GNRC icon
144
Generac Holdings
GNRC
$11.5B
$3.32M 0.15%
+22,280
New +$2.54M
VCYT icon
145
Veracyte
VCYT
$4.45B
$3.27M 0.15%
128,460
+17,560
+16% +$426K
CHDN icon
146
Churchill Downs
CHDN
$6.17B
$3.26M 0.15%
23,430
+1,190
+5% +$163K
ALSN icon
147
Allison Transmission
ALSN
$9.51B
$3.25M 0.15%
57,630
-20,160
-26% -$992K
RVNC
148
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.18M 0.14%
125,727
+23,140
+23% +$721K
TMCI icon
149
Treace Medical Concepts
TMCI
$262M
$3.17M 0.14%
123,780
-5,470
-4% -$141K
ARWR icon
150
Arrowhead Research
ARWR
$12.1B
$3.06M 0.14%
+85,690
New +$2.95M

Similar funds

Castleark Management's Q2 2023 Portfolio in Review

As of Q2 2023, Castleark Management held 326 positions worth $2.21B, up 8.5% from $2.04B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Castleark Management's Q2 2023 filing shows 54 new, 55 increased, 104 reduced and 52 closed positions. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 161,360 shares worth $20.8M. The largest sale was Ulta Beauty, an estimated $38.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Castleark Management's largest Q2 2023 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 161,360 shares worth $20.8M.
  • Castleark Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $38M increase.
  • Castleark Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $30.4M.
  • Castleark Management fully exited Ulta Beauty in Q2 2023, selling an estimated $38.5M.
  • Castleark Management's ten largest holdings make up 36% of its $2.21B portfolio in Q2 2023.
  • Castleark Management opened 54 new positions and closed 52 in Q2 2023.
  • Castleark Management's portfolio value rose 8.5% quarter-over-quarter to $2.21B.

Based on Castleark Management's 13F filing for Q2 2023, filed 16 Aug 2023.